Polar Capital’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Polar Capital’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$30.1M	Hold	2,568,385	–	–	0.22%	102
2020 Q2	$33.4M	Hold	2,568,385	–	–	0.29%	95
2020 Q1	$23.8M	Hold	2,568,385	–	–	0.26%	114
2019 Q4	$42.6M	Hold	2,568,385	–	–	0.37%	88
2019 Q3	$42.7M	Hold	2,568,385	–	–	0.38%	79
2019 Q2	$35.3M	Buy	2,568,385 +10,412	+0.4%	+$159K	0.31%	104
2019 Q1	$44.1M	Hold	2,557,973	–	–	0.41%	84
2018 Q4	$32.7M	Buy	2,557,973 +58,351	+2%	+$885K	0.35%	96
2018 Q3	$40.6M	Sell	2,499,622 -400	-0%	-$5.72K	0.35%	91
2018 Q2	$32.2K	Hold	2,500,022	–	–	0.19%	110
2018 Q1	$31.1M	Buy	2,500,022 +35,000	+1%	+$426K	0.31%	114
2017 Q4	$34.4M	Buy	2,465,022 +100,000	+4%	+$1.46M	0.36%	88
2017 Q3	$39.7M	Buy	2,365,022 +262,545	+12%	+$4.27M	0.45%	72
2017 Q2	$35.4M	Buy	2,102,477 +47,108	+2%	+$704K	0.48%	72
2017 Q1	$31.8M	Buy	2,055,369 +322,766	+19%	+$4.61M	0.48%	69
2016 Q4	$25.9M	Buy	1,732,603 +239,420	+16%	+$3.36M	0.41%	77
2016 Q3	$18.8M	Buy	1,493,183 +152,312	+11%	+$1.53M	0.32%	102
2016 Q2	$12.1M	Buy	1,340,871 +978	+0.1%	+$9.58K	0.23%	124
2016 Q1	$13.3M	Buy	1,339,893 +31,502	+2%	+$323K	0.25%	112
2015 Q4	$15M	Buy	1,308,391 +259,773	+25%	+$3.21M	0.27%	108
2015 Q3	$14.2M	Buy	1,048,618 +175,629	+20%	+$2.38M	0.29%	112
2015 Q2	$12.1M	Buy	872,989 +369,978	+74%	+$5M	0.23%	131
2015 Q1	$7.08M	Buy	503,011 +476,927	+1,828%	+$6.49M	0.13%	152
2014 Q4	$355K	Buy	26,084 +12,403	+91%	+$170K	0.01%	266
2014 Q3	$209K	Buy	13,681 +3,292	+32%	+$50.4K	﹤0.01%	267
2014 Q2	$175K	Buy	+10,389	New	+$187K	﹤0.01%	264
2014 Q1	–	Sell	-301,078	Closed	-$5.83M	–	283
2013 Q4	$5.83M	Buy	+301,078	New	+$5.32M	0.14%	183

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Polar Capital's OXFD Position: Q3 2020 in Review

Polar Capital held its Oxford Immunotec Global PLC Ordinary Shares (OXFD) position steady in Q3 2020 at 2,568,385 shares worth $30.1M. The position accounts for 0.22% of the portfolio, ranked #102.

Polar Capital first reported a position in OXFD in Q4 2013 and has held it in 27 quarters since. The position peaked at $44.1M in Q1 2019. 71 funds tracked by Wall St. Rank hold OXFD as of Q3 2020.

Polar Capital held 2,568,385 shares of Oxford Immunotec Global PLC Ordinary Shares worth $30.1M as of Q3 2020.
Polar Capital left its Oxford Immunotec Global PLC Ordinary Shares share count unchanged in Q3 2020.
Oxford Immunotec Global PLC Ordinary Shares made up 0.22% of Polar Capital's portfolio in Q3 2020, its #102 holding.
Polar Capital first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and has held it in 27 quarters since.
Polar Capital's Oxford Immunotec Global PLC Ordinary Shares position peaked at $44.1M in Q1 2019.
71 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.